RFC
ANIP icon

Regions Financial Corp’s ANI Pharmaceuticals ANIP Stock Holding History

Regions Financial Corp’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11
Closed -$1K – 2072
2018
Q1 		$1K Sell
11
-14
-56% -$889 ﹤0.01% 1905
2017
Q4 		$2K Buy
+25
New +$1.55K ﹤0.01% 1882
2017
Q2 		– Sell
-13,872
Closed -$687K – 890
2017
Q1 		$687K Sell
13,872
-3,187
-19% -$179K 0.01% 587
2016
Q4 		$1.03M Buy
17,059
+13,847
+431% +$847K 0.01% 500
2016
Q3 		$213K Buy
+3,212
New +$201K ﹤0.01% 844
2015
Q4 		– Sell
-15,632
Closed -$618K – 911
2015
Q3 		$618K Buy
+15,632
New +$889K 0.01% 589

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Regions Financial Corp's ANIP Position: Q2 2018 in Review

Regions Financial Corp sold out of ANI Pharmaceuticals (ANIP) in Q2 2018, closing a stake of 11 shares — an estimated $1K sold.

Regions Financial Corp first reported a position in ANIP in Q3 2015 and held it in 6 quarters. The position peaked at $1.03M in Q4 2016. 184 funds tracked by Wall St. Rank hold ANIP as of Q2 2018.

  • Regions Financial Corp reported no remaining ANI Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Regions Financial Corp sold 11 ANI Pharmaceuticals shares in Q2 2018, an estimated $1K.
  • Regions Financial Corp first reported a position in ANI Pharmaceuticals in Q3 2015 and held it in 6 quarters.
  • Regions Financial Corp's ANI Pharmaceuticals position peaked at $1.03M in Q4 2016.
  • 184 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2018.

Based on Regions Financial Corp's 13F filing for Q2 2018, filed 26 Jul 2018.